Role alpha-reductase inhibitors treatment advanced prostatic carcinoma Everything biology prostate concept DHT obligate androgen responsible normal hyperplastic growth selectivity malignant transformation unknown consistent emergence androgen-insensitive disease spectrum biologic evolution cancer capable tumor dependent DHT neoplastic growth unique characteristics alpha-reductase inhibitor offer several potential actions systematic evaluation 